Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Joinn Labs of China Buys Bayer’s San Francisco-Area Campus

publication date: Jan 8, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Joinn Laboratories, a pre-clinical CRO with facilities in Beijing and Taicang, bought the major biopharma campus in the San Francisco Bay area that formerly belonged to Bayer. Joinn, which was founded in 1995, is implementing a “go-big” strategy. It wants to offer major pharmaceutical companies the ability to work on several major projects simultaneously, minimizing the number of CRO contacts each pharma must maintain. Toward that end, Joinn is also building a 1.2 million square foot lab/office space in Taicang, in addition to its newly acquired facility in California. More details....

Stock Symbol: (Xetra: BAY)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors